Search

everythinglearnresearchcommunity

for

Search:↓

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

A biomarker-guided approach can improve alopecia treatment by targeting specific pathways.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

High TSPEAR levels in colorectal cancer predict worse outcomes.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Researchers identified potential markers for human hair color stem cells.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

AMH is a reliable marker for diagnosing PCOS.

DNA markers can predict physical traits for forensic use, but there are ethical and technical challenges.

Women with different PCOS types have similar fertility treatment results.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Certain hair and scalp features can predict the severity of alopecia areata.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Disease-specific tools better assess quality of life in alopecia areata patients.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Eyebrow follicles are best for accurate genetic testing after stem cell transplants.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.